Breakthrough pancreatic cancer treatment could double survival time

Good News: School’s challenge goes viral to support boy battling cancer 01:50 Security scares prompt diversions on two United flights 01:28 U.S. and Iran dig in as talks to end war stall 01:39 Sky-high cost for NBA Finals tickets 01:25 Urgent search for suspect in deputy’s killing 01:04 Now Playing Breakthrough pancreatic cancer treatment could double survival time 02:32 UP NEXT France detains hundreds after violent clashes after soccer win 01:07 Maine Democratic Senate candidate under scrutiny over explicit texts 02:10 Curfew in place to crack down on clashes outside immigration facility 02:01 Inside China's push for global dominance: Evs, robotics, AI, pandas 22:54 Trump to hold rally at ‘Great America State Fair’ after artists back out 01:27 Good News: First-generation college graduates thank their families 02:57 Top W.H.O. official in Ebola epicenter as deadly outbreak spreads 01:44 A.I. lobbyists in statehouses across the U.S. 03:36 Dueling protests face off at New Jersey ICE detention center over detainee conditions 01:49 Mysterious loud boom rattles New England region 01:34 Four more men rescued after more than a week trapped in a flooded cave in Laos 02:08 Great Americans: A conversation with Ruby Bridges 04:33 Several artists back out of celebration for America’s 250th birthday 01:43 Trump to make ‘final determination’ on nuclear deal with Iranian regime 00:57 Nightly News Breakthrough pancreatic cancer treatment could double survival time 02:32 Copied A new study on a groundbreaking pancreatic cancer drug finds that it has the potential to double survival rates for more than 90 percent of patients. Researchers are now exploring whether the drug, called daraxonrasib, could also be effective in lung, ovarian, and colorectal cancers. NBC News’ Erika Edwards reports.May 31, 2026